Alain Labelle, MD
- 2Articles
- 6.7KReads
- 2008–2011Active
- 13Collaborators
- 30Citations
About
Alain Labelle, MD, has published research focused on the treatment of schizophrenia and schizoaffective disorders. His work includes studies on the safety and tolerability of high-dose quetiapine and the use of long-acting injectable risperidone with attention to striatal dopamine D2 receptor occupancy. His articles were published between 2008 and 2011 in Psychiatrist.com journals.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
